DOI QR코드

DOI QR Code

Anti-LGI1 Encephalitis Presented With Prominent Psychosis Without Loss of Consciousness

  • Ja Hyeon Cho (Department of Neurology, Dong-A University Hospital) ;
  • Sun Jung Kim (Department of Neurology, Dong-A University Hospital) ;
  • Kyung Won Park (Department of Neurology, Dong-A University Hospital)
  • 투고 : 2023.02.12
  • 심사 : 2023.04.24
  • 발행 : 2023.04.30

초록

키워드

참고문헌

  1. Choi S, Kim DH, Lee HJ, Shin DJ. Anti-LGI1 antibody limbic encephalitis associated with hepatocellular carcinoma. J Korean Neurol Assoc 2020;38:272-275. 
  2. van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 2016;87:1449-1456. 
  3. Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jackson M, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-78. 
  4. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 2010;81:1167-1169. 
  5. Gastaldi M, Thouin A, Vincent A. Antibody-mediated autoimmune encephalopathies and immunotherapies. Neurotherapeutics 2016;13:147-162. 
  6. Navarro V, Kas A, Apartis E, Chami L, Rogemond V, Levy P, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 2016;139:1079-1093.